The potential for a tripledemic has doctors reminding people there is still time to get vaccinated for all three.
NEW HYDE PARK, N.Y. -- Medical experts are warning about the 1-2-3 punch of respiratory infections that could soon fill our emergency rooms -- flu, COVID-19, and RSV.Nine-year-old Penelope Wood just tested positive for RSV, which she said is like a cold, but only worse.'I have a fever right now and my throat is kind of hurting and my nose is stuffy,' she said.The highly contagious virus is rampant.
READ MORE: COVID, flu and RSV: Expert advice for protecting yourself as virus season approachesPrevention comes first. Doctors recommend what they call the highly effective flu vaccine this year, plus the new COVID vaccine, even for children.'Think of it as more of an insurance policy. You wouldn't have your child or adolescent be in the car without a seatbelt even,' Rubin said.The newly available RSV vaccine is recommended for pregnant women to protect the newborn, and others.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Doctors dealing with shortage of kids RSV prevention drugSupply is so tight, the CDC has advised doctors to prioritize certain patients.
Read more »
Lagging COVID, flu and RSV vaccination rates concern Mass. health officialsFew people are rolling up their sleeves for the new COVID, flu and RSV vaccines, even as peak respiratory virus season is looming, according to state and federal data.
Read more »
GSK PLC Raises Guidance After RSV Vaccine Lifts EarningsGSK said it now expects adjusted operating profit to increase between 13-15% for the year after it reported a rise in net profit in the third quarter, mainly due to the U.S. launch of its Arexvy vaccine.
Read more »
GSK Boosts Profit Forecasts After ‘Outstanding’ RSV Vaccine LaunchI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
GSK Boosts Profit Forecasts After ‘Outstanding’ RSV Vaccine LaunchI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
CDC postpones Alaska shipments of RSV infant immunizationsNirsevimab has just begun to combat infant RSV, and supply is not keeping up with demand.
Read more »